Kanjanapan Y, Lok SW, Gibbs P, De Boer R, et al. Impact of prior (neo)adjuvant trastuzumab (NAT) exposure on the efficacy of HER2-targeted therapy for metastatic breast cancer. Breast Cancer Res Treat 2020 Aug 10. pii: 10.1007/s10549-020-05825.
PMID: 32779037